Mathematical Modelling ofLeprosy and Its Control

Advances in Parasitology

Volumn 87, Issue , 2015, Pages 33-51

  Blok, David J ^a   de Vlas, Sake J ^a   Fischer, Egil A J ^b   Richardus, Jan Hendrik ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Disease control; Epidemiology; Leprosy; Mathematical modelling

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME NURSING; ARTICLE; BCG VACCINATION; COMPARTMENT MODEL; DECISION MAKING; DISEASE ELIMINATION; DISEASE TRANSMISSION; HEALTH CARE NEED; HUMAN; INCUBATION TIME; INNATE IMMUNITY; LEPROSY; LEPROSY CONTROL; LEPROSY EPIDEMIOLOGY; MALARIA; MATHEMATICAL MODEL; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; TUBERCULOSIS; DISEASE ERADICATION; INCIDENCE; THEORETICAL MODEL; TRANSMISSION;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM LEPRAE;

LEPROSTATIC AGENT;

DISEASE ERADICATION; HUMANS; INCIDENCE; LEPROSTATIC AGENTS; LEPROSY; MODELS, THEORETICAL; MYCOBACTERIUM LEPRAE;

EID: 84924433771     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apar.2014.12.002     Document Type: Article

References (57)

1. Adams L.B., Pena M.T., Sharma R., Hagge D.A., Schurr E., Truman R.W. Insights from animal models on the immunogenetics of leprosy: a review. Mem. Inst. Oswaldo Cruz 2012, 107(Suppl. 1):197-208.
2. Alter A., Grant A., Abel L., Alcais A., Schurr E. Leprosy as a genetic disease. Mamm. Genome 2011, 22:19-31.
3. Anonymous International meeting on epidemiology of leprosy in relation to control held in Jakarta, Indonesia, 17-21 June 1991. Lepr. Rev. 1992, 63:1s-126s.
4. Araujo S., Lobato J., Reis Ede M., Souza D.O., Goncalves M.A., Costa A.V., Goulart L.R., Goulart I.M. Unveiling healthy carriers and subclinical infections among household contacts of leprosy patients who play potential roles in the disease chain of transmission. Mem. Inst. Oswaldo Cruz 2012, 107(Suppl. 1):55-59.
5. Bakker M.I., Hatta M., Kwenang A., Faber W.R., Van Beers S.M., Klatser P.R., Oskam L. Population survey to determine risk factors for Mycobacterium leprae transmission and infection. Int. J. Epidemiol. 2004, 33:1329-1336.
6. Bakker M.I., May L., Hatta M., Kwenang A., Klatser P.R., Oskam L., Houwing-Duistermaat J.J. Genetic, household and spatial clustering of leprosy on an island in Indonesia: a population-based study. BMC Med. Genet. 2005, 6:40.
7. Britton W.J., Lockwood D.N. Leprosy. Lancet 2004, 363:1209-1219.
8. van Beers S.M., Hatta M., Klatser P.R. Patient contact is the major determinant in incident leprosy: implications for future control. Int. J. Lepr. Other Mycobact. Dis. 1999, 67:119-128.
9. Desikan K.V. Viability of Mycobacterium leprae outside the human body. Lepr. Rev. 1977, 48:231-235.
10. Duthie M.S., Saunderson P., Reed S.G. The potential for vaccination in leprosy elimination: new tools for targeted interventions. Mem. Inst. Oswaldo Cruz 2012, 107(Suppl. 1):190-196.
11. Feenstra S.G., Nahar Q., Pahan D., Oskam L., Richardus J.H. Recent food shortage is associated with leprosy disease in Bangladesh: a case-control study. PLoS Negl. Trop. Dis. 2012, 5:e1029.
12. Fine P.E. Leprosy: the epidemiology of a slow bacterium. Epidemiol. Rev. 1982, 4:161-188.
13. Fine P.E., Smith P.G. Vaccination against leprosy-the view from 1996. Lepr. Rev. 1996, 67:249-252.
14. Fine P.E., Sterne J.A., Ponnighaus J.M., Bliss L., Saui J., Chihana A., Munthali M., Warndorff D.K. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am. J. Epidemiol. 1997, 146:91-102.
15. Fischer E., Pahan D., Chowdhury S., Richardus J. The spatial distribution of leprosy cases during 15 years of a leprosy control program in Bangladesh: an observational study. BMC Infect. Dis. 2008, 8:126.
16. Fischer E., Vlas D.S., Meima A., Habbema D., Richardus J. Different mechanisms for heterogeneity in leprosy susceptibility can explain disease clustering within households. PLoS One 2010, 5.
17. Fischer E.A., De Vlas S.J., Habbema J.D., Richardus J.H. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study. PLoS Negl. Trop. Dis. 2011, 5:e1330.
18. Fischer E.a.J., Pahan D., Chowdhury S.K., Oskam L., Richardus J.H. The spatial distribution of leprosy in four villages in Bangladesh: an observational study. BMC Infect. Dis. 2008, 8.
19. Fitness J., Tosh K., Hill A.V. Genetics of susceptibility to leprosy. Genes. Immun. 2002, 3:441-453.
20. Gupte M.D., Kishore Kumar B., Elangovan A., Arokiasamy J. Modelling epidemiology of leprosy. Indian J. Lepr. 2000, 72:305-316.
21. Hatta M., Van Beers S.M., Madjid B., Djumadi A., De Wit M.Y., Klatser P.R. Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:381-385.
22. Lechat M.F. The torments and blessings of the leprosy epidemiometric model. Lepr. Rev. 1981, 52:187-196.
23. Lechat M.F. Epidemiometric modeling in leprosy based on Indian data. Lepr. Rev. 1992, 63:S31-S39.
24. Lechat M.F., Declercq E.E., Mission C.B., Vellut C.M. Selection of MDT strategies through epidemiometric modeling. Int. J. Lepr. 1990, 58:296-301.
25. Lechat M.F., Misson C.B., Bouckaert A., Vellut C. An epidemiometric model of leprosy: a computer simulation of various control methods with increasing coverage. Int. J. Lepr. 1977, 45:1-8.
26. Lechat M.F., Misson C.B., Lambert A. Simulation of vaccination and resistance in leprosy using an epidemiometric model. Int. J. Lepr. 1985, 53:461-467.
27. Lechat M.F., Misson C.B., Vanderveken M. A computer simulation of the effect of multidrug therapy on the incidence of leprosy. Ann. Soc. BELG Med. Trop. 1987, 67:59-65.
28. Lechat M.F., Misson J.Y., Vellut C.M. An epidemetric model of leprosy. Bull. WHO 1974, 51:361-373.
29. Lietman T., Porco T., Blower S. Leprosy and tuberculosis: the epidemiological consequences of cross-immunity. Am. J. Public Health 1997, 87:1923-1927.
30. Meima A., Gupte M.D., Van Oortmarssen G.J., Habbema J.D.F. SIMLEP: a simulation model for leprosy transmission and control. Int. J. Lepr. Other Mycobact. Dis. 1999, 67:215-236.
31. Meima A., Irgens L.M., Van Oortmarssen G.J., Richardus J.H., Habbema J.D. Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach. Int. J. Epidemiol. 2002, 31:991-1000.
32. Meima A., Smith W.C., Van Oortmarssen G.J., Richardus J.H., Habbema J.D. The future incidence of leprosy: a scenario analysis. Bull. World Health Organ. 2004, 82:373-380.
33. Meima A., Van Veen N.H., Richardus J.H. Future prevalence of WHO grade 2 impairment in relation to incidence trends in leprosy: an exploration. Trop. Med. Int. Health 2008, 13:241-246.
34. Mira M.T., Alcais A., Di Pietrantonio T., Thuc N.V., Phuong M.C., Abel L., Schurr E. Segregation of HLA/TNF region is linked to leprosy clinical spectrum in families displaying mixed leprosy subtypes. Genes. Immun. 2003, 4:67-73.
35. Mira M.T., Alcais A., Nguyen V.T., Moraes M.O., Di Flumeri C., Vu H.T., Mai C.P., Nguyen T.H., Nguyen N.B., Pham X.K., Sarno E.N., Alter A., Montpetit A., Moraes M.E., Moraes J.R., Dore C., Gallant C.J., Lepage P., Verner A., Van De Vosse E., Hudson T.J., Abel L., Schurr E. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004, 427:636-640.
36. Moet F.J., Meima A., Oskam L., Richardus J.H. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr. Rev. 2004, 75:310-326.
37. Moet F.J., Pahan D., Oskam L., Richardus J.H. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ 2008, 336:761-764.
38. Moet F.J., Pahan D., Schuring R.P., Oskam L., Richardus J.H. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J. Infect. Dis. 2006, 193:346-353.
39. Montenegro A.C., Werneck G.L., Kerr-Pontes L.R., Barreto M.L., Feldmeier H. Spatial analysis of the distribution of leprosy in the State of Ceara, Northeast Brazil. Mem. Inst. Oswaldo Cruz 2004, 99:683-686.
40. Noordeen S.K. The epidemiology of leprosy. Leprosy 1985, Churchill Livingstone, Edinburgh. R.C. Hastings (Ed.).
41. Opromolla P.A., Dalben I., Cardim M. Geostatistical analysis of leprosy cases in the State of Sao Paulo, 1991-2002. Rev. Saude Publica 2006, 40:907-913.
42. Rao P.S., Karat A.B., Kaliaperumal V.G., Karat S. Transmission of leprosy within households. Int. J. Lepr. Other Mycobact. Dis. 1975, 43:45-54.
43. Richardus J.H., Habbema J.D.F. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?. Lepr. Rev. 2007, 78:330-337.
44. Richardus J.H., Meima A., Van Marrewijk C.J., Croft R.P., Smith T.C. Close contacts with leprosy in newly diagnosed leprosy patients in a high and low endemic area: comparison between Bangladesh and Thailand. Int. J. Lepr. Other Mycobact. Dis. 2005, 73:249-257.
45. Rodrigues L.C., Lockwood D.N. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect. Dis. 2011, 11:464-470.
46. Schuring R.P., Richardus J.H., Pahan D., Oskam L. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention. Vaccine 2009, 27:7125-7128.
47. Smith C., Richardus J.H. Leprosy strategy is about control, not eradication. Lancet 2008, 371:969-970.
48. Sterne J.A., Ponnighaus J.M., Fine P.E., Malema S.S. Geographic determinants of leprosy in Karonga district, northern Malawi. Int. J. Epidemiol. 1995, 24:1211-1222.
49. Turankar R.P., Lavania M., Chaitanya V.S., Sengupta U., Darlong J., Darlong F., Siva Sai K.S., Jadhav R.S. Single nucleotide polymorphism-based molecular typing of M. leprae from multicase families of leprosy patients and their surroundings to understand the transmission of leprosy. Clin. Microbiol. Infect. 2014, 20:O142-O149.
50. Wallinga J., Edmunds W.J., Kretzschmar M. Perspective: human contact patterns and the spread of airborne infectious diseases. Trends Microbiol. 1999, 7:372-377.
51. Elimination of Leprosy: Resolution of the 44th World Health Assembly (Resolution No. WHA 44.9) 1991, WHO, WHO, Geneva.
52. Chemotherapy of leprosy. World Health Organ. Tech. Rep. Ser. 1994, 847:1-24. WHO.
53. WHO expert committee on leprosy. World Health Organ. Tech. Rep. Ser. 1998, 874:1-43. WHO.
54. Enhanced Global Strategy for Further Reducing the Disease Burden Due to Leprosy (Plan Period: 2011-2015) [Online] 2009, WHO, World Health Organization, Regional Office for South-East Asia, New Delhi, Available:, (accessed 17.05.13.). http://www.searo.who.int/entity/leprosy/documents/SEA_GLP_2009_3/en/index.html.
55. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases - a Roadmap for Implementation 2012, WHO, World Health Organization, Geneva, Switzerland.
56. Global leprosy: update on the 2012 situation. Wkly. Epidemiol. Rec. 2013, 88:365-380. WHO.
57. Zhang F.R., Huang W., Chen S.M., Sun L.D., Liu H., Li Y., Cui Y., Yan X.X., Yang H.T., Yang R.D., Chu T.S., Zhang C., Zhang L., Han J.W., Yu G.Q., Quan C., Yu Y.X., Zhang Z., Shi B.Q., Zhang L.H., Cheng H., Wang C.Y., Lin Y., Zheng H.F., Fu X.A., Zuo X.B., Wang Q., Long H., Sun Y.P., Cheng Y.L., Tian H.Q., Zhou F.S., Liu H.X., Lu W.S., He S.M., Du W.L., Shen M., Jin Q.Y., Wang Y., Low H.Q., Erwin T., Yang N.H., Li J.Y., Zhao X., Jiao Y.L., Mao L.G., Yin G., Jiang Z.X., Wang X.D., Yu J.P., Hu Z.H., Gong C.H., Liu Y.Q., Liu R.Y., Wang D.M., Wei D., Liu J.X., Cao W.K., Cao H.Z., Li Y.P., Yan W.G., Wei S.Y., Wang K.J., Hibberd M.L., Yang S., Zhang X.J., Liu J.J. Genomewide association study of leprosy. N. Engl. J. Med. 2009, 361:2609-2618.